Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09GCE
|
||||
| Former ID |
DNC013321
|
||||
| Drug Name |
(S)-N2-{4-[(4-nitrobenzyl)oxy]benzyl}serinamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529025] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H19N3O5
|
||||
| Canonical SMILES |
C1=CC(=CC=C1CNC(CO)C(=O)N)OCC2=CC=C(C=C2)[N+](=O)[O-]
|
||||
| InChI |
1S/C17H19N3O5/c18-17(22)16(10-21)19-9-12-3-7-15(8-4-12)25-11-13-1-5-14(6-2-13)20(23)24/h1-8,16,19,21H,9-11H2,(H2,18,22)/t16-/m0/s1
|
||||
| InChIKey |
XVFXQICJBNSYEW-INIZCTEOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [529025] | |
| KEGG Pathway | Glycine, serine and threonine metabolism | ||||
| Arginine and proline metabolism | |||||
| Histidine metabolism | |||||
| Tyrosine metabolism | |||||
| Phenylalanine metabolism | |||||
| Tryptophan metabolism | |||||
| Drug metabolism - cytochrome P450 | |||||
| Metabolic pathways | |||||
| Serotonergic synapse | |||||
| Dopaminergic synapse | |||||
| Cocaine addiction | |||||
| Amphetamine addiction | |||||
| Alcoholism | |||||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.